RENEURON GROUP PLC Chart calendar ReNeuron Group Plc
7582f8dfedf3947aabff29a7cca1893.fs5CqiPWSHUX6GC9ogxvGugQuiKdkUOH-PaQmUrZLQU.JqsKwFuCMkZ93CuOxW8MVN5C42_09nvJzamk8RKAT25J_iXdduIwHX7eFw~358cb49459617f82c1e6d2e16f0e6470
Upcoming events on ReNeuron Group Plc
Past events on ReNeuron Group Plc
| 2023-11-08 02:01 am | Q2 2024 Earnings Release |
| 2023-08-22 04:30 am | Annual General Meeting |
| 2023-05-25 04:30 am | Q4 2023 Earnings Call |
| 2023-05-25 02:00 am | Q4 2023 Earnings Release |
| 2023-03-13 | Advanced Therapies conference |
| 2022-12-02 02:00 am | Interim 2023 Earnings Release |
| 2022-10-03 | Therapeutic Development Summit |
| 2022-09-09 04:30 am | Annual General Meeting |
| 2022-07-04 10:00 am | FY 2022 Earnings Call - Second Call |
| 2022-07-04 08:00 am | FY 2022 Earnings Call - First Call |
| 2022-07-04 02:00 am | FY 2022 Earnings Release |
| 2022-05-07 10:35 am | International Society of Cell and Gene Therapy Meeting |
| 2022-05-05 11:45 am | International Society of Cell and Gene Therapy Meeting |
| 2022-02-04 07:00 am | Strategic Update Call |
| 2021-11-30 10:00 am | Interim 2022 Earnings Call - Second Call |
| 2021-11-30 08:00 am | Interim 2022 Earnings Call - First Call |
| 2021-11-30 02:00 am | Interim 2022 Earnings Release |
| 2021-09-16 05:00 am | Annual General Meeting |
| 2021-07-08 11:30 am | FY 2021 Earnings Call |
| 2021-07-08 02:00 am | FY 2021 Earnings Release |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 0,05 1,97 -97.51% | 6,17 6,30 -2.1% | 0,26 0,50 -48.19% | 0,40 0,28 46.55% | 0,53 0,64 -17.38% |
|
EBITDA Million GBP | Released Forecast Spread | -18,0 -21,1 14.65% | -14,0 -21,5 35.05% | -12,5 -14,1 11.24% | -10,9 -10,7 -1.82% | -6,85 0,00 - |
|
EBIT Million GBP | Released Forecast Spread | -18,3 -21,4 14.54% | -14,4 -20,3 28.91% | -12,9 -14,7 12.1% | -11,2 -11,7 4.12% | -7,12 -8,51 16.35% |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -17,2 -17,7 2.72% | -13,9 -22,8 39.17% | -13,4 -14,9 9.76% | -11,1 -11,7 5.66% | -6,66 -8,24 19.21% |
|
Net income Million GBP | Released Forecast Spread | -14,3 -15,4 7.06% | -11,4 -19,2 40.57% | -11,3 -13,4 15.07% | 0,00 0,00 - | -5,41 -6,92 21.83% |
|
EPS GBP | Released Forecast Spread | -0,45 -0,49 7.13% | -0,36 -0,60 40.49% | -0,29 -0,33 11.72% | 0,00 0,00 - | -0,10 -0,12 20.5% |
| Announcement Date | 11/07/19 | 20/07/20 | 08/07/21 | 04/07/22 | 25/05/23 |
Quarterly results
| Fiscal Period | March | 2020 S1 | 2021 S2 |
|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 0,22 1,00 -78.4% | |
|
EBIT Million GBP | Released Forecast Spread | -5,71 -5,11 -11.81% | 5,17 -6,70 177.22% |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -5,14 -5,11 -0.72% | |
|
Net income Million GBP | Released Forecast Spread | -3,90 -5,11 23.67% | |
|
EPS GBP | Released Forecast Spread | -0,12 -0,16 24.54% | |
| Announcement Date | 06/12/19 | 08/07/21 |
More events
Past sector events for ReNeuron Group Plc
| 2024-04-17 | HINOVA PHARMACEUTICALS INC.: Q4 2023 Earnings Release |
| 2024-04-17 02:07 am | TELIX PHARMACEUTICALS LIMITED: March 2024 Sales and Revenue Release - Activities Report |
| 2024-04-10 04:10 pm | PHARVARIS N.V.: Q4 2023 Earnings Release |
| 2024-04-10 01:22 am | POLARIS GROUP: March 2024 Sales and Revenue Release |
| 2024-04-02 02:30 am | ABIVAX: Q4 2023 Earnings Release |
| 2024-04-01 09:00 am | BIOMEA FUSION, INC.: Q4 2023 Earnings Release |
| 2024-03-28 10:42 pm | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
| 2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
| 2024-03-28 07:10 am | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
